微小RNA-34a通过下调人肝癌细胞中c-Met的表达来抑制细胞迁移和侵袭。
miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.
作者信息
Li Na, Fu Hanjiang, Tie Yi, Hu Zheng, Kong Wei, Wu Yongge, Zheng Xiaofei
机构信息
Beijing Institute of Radiation Medicine, 27 Taiping Road, Beijing 100850, PR China.
出版信息
Cancer Lett. 2009 Mar 8;275(1):44-53. doi: 10.1016/j.canlet.2008.09.035. Epub 2008 Nov 8.
Several studies have shown that miR-34a represses the expression of many genes and induces G1 arrest, apoptosis, and senescence. In the present study, we identified the role of miR-34a in the regulation of tumor cell scattering, migration, and invasion. Down-regulation of miR-34a expression was highly significant in 19 of 25 (76%) human hepatocellular carcinoma (HCC) tissues compared with adjacent normal tissues and associated with the metastasis and invasion of tumors. Furthermore, resected normal/tumor tissues of 25 HCC patients demonstrated an inverse correlation between miR-34a and c-Met-protein. In HepG2 cells, ectopic expression of miR-34a potently inhibited tumor cell migration and invasion in a c-Met-dependent manner. miR-34a directly targeted c-Met and reduced both mRNA and protein levels of c-Met; thus, decreased c-Met-induced phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2). Taken together, these results provide evidence to show the suppression role of miR-34a in tumor migration and invasion through modulation of the c-Met signaling pathway.
多项研究表明,miR-34a可抑制许多基因的表达,并诱导G1期阻滞、细胞凋亡和衰老。在本研究中,我们确定了miR-34a在调节肿瘤细胞散射、迁移和侵袭中的作用。与相邻正常组织相比,25例人类肝细胞癌(HCC)组织中有19例(76%)miR-34a表达下调非常显著,且与肿瘤的转移和侵袭相关。此外,对25例HCC患者切除的正常/肿瘤组织进行检测,结果显示miR-34a与c-Met蛋白呈负相关。在HepG2细胞中,miR-34a的异位表达以c-Met依赖的方式有效抑制肿瘤细胞的迁移和侵袭。miR-34a直接靶向c-Met,降低c-Met的mRNA和蛋白水平;因此,减少了c-Met诱导的细胞外信号调节激酶1和2(ERK1/2)的磷酸化。综上所述,这些结果证明miR-34a通过调节c-Met信号通路在肿瘤迁移和侵袭中发挥抑制作用。